-+ 0.00%
-+ 0.00%
-+ 0.00%

Oric Pharmaceuticals shareholders approve amended, restated 2020 equity incentive plan

PUBT·06/22/2026 20:06:07
Listen to the news
Oric Pharmaceuticals shareholders approve amended, restated 2020 equity incentive plan
  • Oric Pharmaceuticals held its annual shareholder meeting on June 18, 2026.
  • Shareholders adopted an amended and restated 2020 Equity Incentive Plan, effective June 18, 2026.
  • Investors ratified KPMG as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Holders backed an annual cadence for future advisory votes on executive pay.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-277511), on June 22, 2026, and is solely responsible for the information contained therein.